RM Global Health

www.rmgh.net

 
  • Increase font size
  • Default font size
  • Decrease font size
  • default color
  • green color
  • blue color

EU Agency Backs Schering-Plough Anaesthesia Drug

Monday, 16 June 2008 23:16 Ramaz Mitaishvili
E-mail Print PDF
A new drug from Schering-Plough Corp aimed at helping patients emerge more quickly from anaesthesia has been recommended for approval in Europe, the region's medicines watchdog said on Monday.

The European Medicines Agency said Bridion, also known generically as sugammadex, was recommended for the reversal of neuromuscular block induced by rocuronium or vecuronium.

Recommendations for marketing approval by the agency's Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months.

Schering-Plough acquired the drug after buying Organon BioSciences, the drugs arm of Akzo Nobel, last year.

A U.S. Food and Drug Administration expert panel voted in March that the drug was safe and effective.

Reviewed by Ramaz Mitaishvili, MD
 

West Nile virus is a significant health threat. Transmitted by mosquitoes, its symptoms include     headaches, fever, fatigue and muscle aches. Most people recover, but the disease can be fatal. No   vaccine exists. but there are steps you can take to protect yourself, when travel.
 
1. Wear Long Sleeve Shirts and Pants Outdoors
2. Use Mosquito Repellents Containing DEET

West Nile Virus
3. Secure Window and Door Screens


Alerts

Can Pharmacists Improve the Accuracy of Medication Histories? Can Pharmacists Improve the Accuracy of Medication Histories? Reviewed by Ramaz Mitaishvili, MD 
 
Why Should I Report an Adverse Drug Event? When I was in charge of the postmarketing drug safety program at the US Food and Drug Administration (FDA) in the early ...
 
Russian Navy Blockades Humanitarian Wheat Shipment to Georgia The Navy of the Russian Federation today appeared to have taken a further escalatory step in its aggressive war against ...